<meta http-equiv="Content-Type" content="text/html; charset=utf-8"><link type="text/css" rel="stylesheet" href="resources/sheet.css" >
<style type="text/css">.ritz .waffle a { color: inherit; }.ritz .waffle .s0{background-color:#ffffff;text-align:left;color:#000000;font-family:'docs-Cabin',Arial;font-size:10pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s2{border-right: none;background-color:#ffffff;text-align:left;font-weight:bold;color:#000000;font-family:'docs-Cabin',Arial;font-size:10pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s3{border-right: none;background-color:#ffffff;text-align:left;color:#000000;font-family:'docs-Cabin',Arial;font-size:10pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s1{background-color:#ffffff;text-align:left;font-weight:bold;color:#000000;font-family:'docs-Cabin',Arial;font-size:10pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}</style><div class="ritz grid-container" dir="ltr"><table class="waffle" cellspacing="0" cellpadding="0"><thead><tr><th class="row-header freezebar-origin-ltr"></th><th id="2069507430C0" style="width:100px;" class="column-headers-background">A</th></tr></thead><tbody><tr style="height: 20px"><th id="2069507430R0" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">1</div></th><td class="s0"></td></tr><tr style="height: 20px"><th id="2069507430R1" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">2</div></th><td class="s0"></td></tr><tr style="height: 20px"><th id="2069507430R2" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">3</div></th><td class="s1" dir="ltr"></td></tr><tr style="height: 20px"><th id="2069507430R3" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">4</div></th><td class="s0"></td></tr><tr style="height: 20px"><th id="2069507430R4" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">5</div></th><td class="s2 softmerge" dir="ltr"><div class="softmerge-inner" style="width:198px;left:-1px">Lifestyle interventions</div></td></tr><tr style="height: 20px"><th id="2069507430R5" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">6</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:498px;left:-1px">1) recommend a trial of caffeine reduction to women with overactive bladder</div></td></tr><tr style="height: 20px"><th id="2069507430R6" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">7</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:798px;left:-1px">2) consider advising women with urinary incontinence or overactive bladder and a high or low fluid intake to modify their fluid intake.</div></td></tr><tr style="height: 20px"><th id="2069507430R7" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">8</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:698px;left:-1px">3) advise women with urinary incontinence or overactive bladder who have a BMI greater than 30 to lose weight.</div></td></tr><tr style="height: 20px"><th id="2069507430R8" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">9</div></th><td class="s0"></td></tr><tr style="height: 20px"><th id="2069507430R9" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">10</div></th><td class="s2 softmerge" dir="ltr"><div class="softmerge-inner" style="width:198px;left:-1px">Physical therapies</div></td></tr><tr style="height: 20px"><th id="2069507430R10" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">11</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:1198px;left:-1px">1) Pelvic floor muscle training - offer a trial of supervised pelvic floor muscle training of at least 3 months&#39; duration as first-line treatment to women with stress}} or mixed urinary incontinence</div></td></tr><tr style="height: 20px"><th id="2069507430R11" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">12</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:698px;left:-1px">2) Pelvic floor muscle training programmes should comprise at least 8 contractions performed 3 times per day.</div></td></tr><tr style="height: 20px"><th id="2069507430R12" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">13</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:498px;left:-1px">3) continue an exercise programme if pelvic floor muscle training is beneficial.</div></td></tr><tr style="height: 20px"><th id="2069507430R13" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">14</div></th><td class="s0"></td></tr><tr style="height: 20px"><th id="2069507430R14" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">15</div></th><td class="s2 softmerge" dir="ltr"><div class="softmerge-inner" style="width:198px;left:-1px">Electrical stimulation</div></td></tr><tr style="height: 20px"><th id="2069507430R15" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">16</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:998px;left:-1px">Electrical stimulation and/or biofeedback should be considered for women who cannot actively contract pelvic floor muscles to aid motivation and adherence to therapy</div></td></tr><tr style="height: 20px"><th id="2069507430R16" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">17</div></th><td class="s0"></td></tr><tr style="height: 20px"><th id="2069507430R17" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">18</div></th><td class="s2 softmerge" dir="ltr"><div class="softmerge-inner" style="width:198px;left:-1px">Behavioural therapies</div></td></tr><tr style="height: 20px"><th id="2069507430R18" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">19</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:798px;left:-1px">1) Offer bladder training lasting for a minimum of 6 weeks as first-line treatment to women with urgency or mixed urinary incontinence.</div></td></tr><tr style="height: 20px"><th id="2069507430R19" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">20</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:1298px;left:-1px">2) If women do not achieve satisfactory benefit from bladder training programmes, the combination of an overactive bladder medicine with bladder training should be considered if frequency is a troublesome symptom.</div></td></tr><tr style="height: 20px"><th id="2069507430R20" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">21</div></th><td class="s0"></td></tr><tr style="height: 20px"><th id="2069507430R21" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">22</div></th><td class="s2 softmerge" dir="ltr"><div class="softmerge-inner" style="width:198px;left:-1px">Neurostimulation</div></td></tr><tr style="height: 20px"><th id="2069507430R22" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">23</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:2298px;left:-1px">3) Do not offer {percutaneous posterior tibial nerve stimulation (needles inserted close to the posterior tibial nerve) for overactive bladder unless there has been a local MDT review and non-surgical management including overactive bladder medicine treatment has not worked adequately and the woman does not want botulinum toxin type A or percutaneous sacral nerve stimulation.</div></td></tr><tr style="height: 20px"><th id="2069507430R23" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">24</div></th><td class="s0" dir="ltr"></td></tr><tr style="height: 20px"><th id="2069507430R24" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">25</div></th><td class="s2 softmerge" dir="ltr"><div class="softmerge-inner" style="width:398px;left:-1px">Absorbent containment products, urinals and toileting aids</div></td></tr><tr style="height: 20px"><th id="2069507430R25" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">26</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:798px;left:-1px">Do not offer absorbent containment products, hand-held urinals or toileting aids to treat urinary incontinence. Offer them only:</div></td></tr><tr style="height: 20px"><th id="2069507430R26" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">27</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:298px;left:-1px">as a coping strategy pending definitive treatment</div></td></tr><tr style="height: 20px"><th id="2069507430R27" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">28</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:198px;left:-1px">as an adjunct to ongoing therapy</div></td></tr><tr style="height: 20px"><th id="2069507430R28" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">29</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:598px;left:-1px">for long-term management of urinary incontinence only after treatment options have been explored. </div></td></tr><tr style="height: 20px"><th id="2069507430R29" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">30</div></th><td class="s0"></td></tr><tr style="height: 20px"><th id="2069507430R30" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">31</div></th><td class="s2 softmerge" dir="ltr"><div class="softmerge-inner" style="width:1198px;left:-1px">Offer a review at least once a year to women who are using absorbent containment products for long-term management of urinary incontinence. The review should cover:</div></td></tr><tr style="height: 20px"><th id="2069507430R31" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">32</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:298px;left:-1px">routine assessment of continence</div></td></tr><tr style="height: 20px"><th id="2069507430R32" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">33</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:198px;left:-1px">assessment of skin integrity</div></td></tr><tr style="height: 20px"><th id="2069507430R33" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">34</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:698px;left:-1px">changes to symptoms, comorbidities, lifestyle, mobility, medication, BMI, and social and environmental factors</div></td></tr><tr style="height: 20px"><th id="2069507430R34" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">35</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:298px;left:-1px">the suitability of alternative treatment options</div></td></tr><tr style="height: 20px"><th id="2069507430R35" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">36</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:698px;left:-1px">the efficacy of the absorbent containment product the woman is currently using and the quantities used.</div></td></tr><tr style="height: 20px"><th id="2069507430R36" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">37</div></th><td class="s0"></td></tr><tr style="height: 20px"><th id="2069507430R37" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">38</div></th><td class="s2 softmerge" dir="ltr"><div class="softmerge-inner" style="width:998px;left:-1px">Reviews for women who are using absorbent containment products for long-term management of urinary incontinence should be carried out by either:</div></td></tr><tr style="height: 20px"><th id="2069507430R38" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">39</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:798px;left:-1px">a registered healthcare professional who is trained in assessing continence and making referrals to specialist services or</div></td></tr><tr style="height: 20px"><th id="2069507430R39" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">40</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:1098px;left:-1px">a non-registered healthcare worker, under the supervision of a registered healthcare professional who is trained in assessing continence and making referrals to specialist services.</div></td></tr><tr style="height: 20px"><th id="2069507430R40" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">41</div></th><td class="s0"></td></tr><tr style="height: 20px"><th id="2069507430R41" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">42</div></th><td class="s1" dir="ltr">Catheters</td></tr><tr style="height: 20px"><th id="2069507430R42" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">43</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:2498px;left:-1px">Bladder catheterisation (intermittent or indwelling urethral or suprapubic) should be considered for women in whom persistent urinary retention is causing incontinence, symptomatic infections or renal dysfunction, and in whom this cannot otherwise be corrected. Healthcare professionals should be aware, and explain to women, that the use of indwelling catheters in urgency urinary incontinence may not result in continence.</div></td></tr><tr style="height: 20px"><th id="2069507430R43" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">44</div></th><td class="s0"></td></tr><tr style="height: 20px"><th id="2069507430R44" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">45</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:998px;left:-1px">Offer intermittent urethral catheterisation to women with urinary retention who can be taught to self-catheterise or who have a carer who can perform the technique.</div></td></tr><tr style="height: 20px"><th id="2069507430R45" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">46</div></th><td class="s0"></td></tr><tr style="height: 20px"><th id="2069507430R46" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">47</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:1698px;left:-1px">Give careful consideration to the impact of long-term indwelling urethral catheterisation. Discuss the practicalities, benefits and risks with the woman or, if appropriate, her carer. Indications for the use of long-term indwelling urethral catheters for women with urinary incontinence include:</div></td></tr><tr style="height: 20px"><th id="2069507430R47" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">48</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:598px;left:-1px">chronic urinary retention in women who are unable to manage intermittent self-catheterisation</div></td></tr><tr style="height: 20px"><th id="2069507430R48" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">49</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:498px;left:-1px">skin wounds, pressure ulcers or irritations that are being contaminated by urine</div></td></tr><tr style="height: 20px"><th id="2069507430R49" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">50</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:398px;left:-1px">distress or disruption caused by bed and clothing changes</div></td></tr><tr style="height: 20px"><th id="2069507430R50" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">51</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:498px;left:-1px">where a woman expresses a preference for this form of management. </div></td></tr><tr style="height: 20px"><th id="2069507430R51" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">52</div></th><td class="s0"></td></tr><tr style="height: 20px"><th id="2069507430R52" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">53</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:1698px;left:-1px">Indwelling suprapubic catheters should be considered as an alternative to long-term urethral catheters. Be aware, and explain to women, that they may be associated with lower rates of symptomatic UTI, &#39;bypassing&#39;, and urethral complications than indwelling urethral catheters.</div></td></tr><tr style="height: 20px"><th id="2069507430R53" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">54</div></th><td class="s0"></td></tr><tr style="height: 20px"><th id="2069507430R54" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">55</div></th><td class="s2 softmerge" dir="ltr"><div class="softmerge-inner" style="width:198px;left:-1px">Products to prevent leakage</div></td></tr><tr style="height: 20px"><th id="2069507430R55" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">56</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:1598px;left:-1px">Do not use intravaginal and intraurethral devices for the routine management of urinary incontinence in women. Do not advise women to consider such devices other than for occasional use when necessary to prevent leakage, for example during physical exercise}}.Ã‚</div></td></tr><tr style="height: 20px"><th id="2069507430R56" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">57</div></th><td class="s0"></td></tr><tr style="height: 20px"><th id="2069507430R57" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">58</div></th><td class="s2 softmerge" dir="ltr"><div class="softmerge-inner" style="width:198px;left:-1px">Complementary therapies</div></td></tr><tr style="height: 20px"><th id="2069507430R58" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">59</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:698px;left:-1px">Do not recommend complementary therapies for the treatment of urinary incontinence or overactive bladder.</div></td></tr></tbody></table></div>